Levee Medical’s main product, the Voro urologic scaffold, is designed to treat prostatectomy urinary incontinence. The latest funding will be used to advance product development for the Voro urologic scaffold, according to the Aug. 23 Levee Medical news release.
The Voro urologic scaffold, which is placed during prostatectomy surgery, is the first bioresorbable device used to treat prostatectomy urinary incontinence, according to the news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
